SenolyticsShop.com
Your Support Drives Innovation. Shop Now, Donate Here.
 |
 |
 |
 |
SEO excerpt: “The senolytics field is embroiled in controversy, with debates surrounding the concept of senescence and the efficacy of senolytic therapies. Despite challenges, experts remain optimistic about the potential of senolytics to revolutionize healthy aging. Read on to explore the key points of contention and what it means for the future of senolytics.
Read More
The Cutting Edge of Senolytics: New Developments in Removing Harmful Senescent Cells Senolytics...
Read More
Cutting-edge AI drug discovery techniques are unveiling promising novel senolytic compounds that could translate into significant anti-aging and longevity treatments.
Read MoreNature Reviews Drug Discovery – Discover the world’s best science and medicine |...
Read MoreThere’s a good zombie.
Read MoreBuck Institute professor shifts focus to functional studies of senolytic compound with hopes for frailty and sarcopenia.
Read MoreThe Alzheimer’s Drug Discovery Foundation will be moderating a session, “Beyond Amyloid and Tau: Emerging Solutions,” at the 2022 Clinical Trials on Alzheimer’s Disease (CTAD) conference, which will be...
Read MoreFORT LAUDERDALE, Fla. — A senolytic therapy represents a novel approach to treating diabetic macular edema and wet age-related macular degeneration, according to a speaker at the Retina World Congress. Raj Maturi, MD, presented...
Read MoreNature Communications – Monitoring the aging process in vivo is challenging. Here the authors generate a Glb1+/m‒Glb1-2A-mCherry (GAC) reporter mouse model, where the GAC signal is…
Read MoreDublin, May 20, 2022 (GLOBE NEWSWIRE) — The “Global Senolytic Drugs Market, By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine…
Read MoreThe world is rapidly aging. According to the World Health Organization, 12% of the world population was aged 60 and above in 2015 and by 2050, that number will rise to 22%. Along with this demographic shift, there is an increase...
Read MoreClearing out dying cells, approach has implications far beyond ophthalmology
Read More
